Morgan Sheng is a Core Institute Member and Co-Director of the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard. He is also a Professor in the Department of Brain and Cognitive Science at MIT. Previously, Morgan was Vice President of Neuroscience at Genentech, a leading biotech company, where he was head of neuroscience research and drug discovery. Under his leadership, multiple innovative programs for treatment of serious diseases of the nervous system were advanced into clinical trials. Prior to joining Genentech, Morgan was the Menicon Professor of Neuroscience at MIT, as well as an Investigator of the Howard Hughes Medical Institute. He is a Fellow of the Royal Society in the U.K., the Academy of Medical Sciences in the U.K. and the American Association for the Advancement of Science and is the author of more than 200 peer-reviewed publications focused on the molecular cellular biology of brain synapses and the mechanisms of neurodegenerative diseases.

Morgan received a B.A. from Oxford University (UK), and obtained his medical degree and training in internal medicine at London University (UK).  He also holds a PhD in molecular genetics from Harvard University. Following his postdoctoral work in neuroscience at the University of California, San Francisco, he served on the faculty at Massachusetts General Hospital and Harvard Medical School before joining MIT.